US$ 27.71
companies innovating in obesity treatment glp-1 drugs 2025 Unpacking $100B+ Market Opportunity: What It Means for Biopharma, Payers, and Providers GLP-1 Receptor Agonist Market Size,
Description
As these drugs gain momentum, we know we could see a rapid increase for their demand, given their potential to treat many different indications

Bananas, melon, applesauce, and soft pears are often easier to tolerate than very acidic or very fibrous options

Symptoms include shakiness, sweating, confusion, rapid heartbeat, and in severe cases, loss of consciousness

Karmi et al

China has also begun to pay attention to the risk of thyroid cancer induced by GLP-1RA, and this warning has been added to the drug instructions of some GLP-1RAs
